特地唑胺：一种用于革兰氏阳性菌感染的新型恶唑烷酮类药物。 - Suppr

Suppr

超能文献

Tedizolid: a novel oxazolidinone for Gram-positive infections.

作者信息

Moellering Robert C

机构信息

Harvard Medical School.

出版信息

Clin Infect Dis. 2014 Jan;58 Suppl 1:S1-3. doi: 10.1093/cid/cit658.

DOI:10.1093/cid/cit658

PMID:24343826

Abstract

摘要

相似文献

Tedizolid: a novel oxazolidinone for Gram-positive infections.

Clin Infect Dis. 2014 Jan;58 Suppl 1:S1-3. doi: 10.1093/cid/cit658.

Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.

Drugs. 2015 Feb;75(3):253-70. doi: 10.1007/s40265-015-0352-7.

Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.

Pharmacotherapy. 2014 Nov;34(11):1198-208. doi: 10.1002/phar.1491. Epub 2014 Sep 30.

Tedizolid for the management of human infections: in vitro characteristics.

Clin Infect Dis. 2014 Jan;58 Suppl 1:S35-42. doi: 10.1093/cid/cit616.

Results of the surveillance of Tedizolid activity and resistance program: in vitro susceptibility of gram-positive pathogens collected in 2011 and 2012 from the United States and Europe.

Diagn Microbiol Infect Dis. 2015 Feb;81(2):112-8. doi: 10.1016/j.diagmicrobio.2014.08.011. Epub 2014 Aug 30.

Tedizolid: A New Oxazolidinone Antibiotic for Skin and Soft Tissue Infections.

Consult Pharm. 2015 Jul;30(7):386-94. doi: 10.4140/TCP.n.2015.386.

In Vitro and In Vivo Activities of a Bi-Aryl Oxazolidinone, RBx 11760, against Gram-Positive Bacteria.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7134-7145. doi: 10.1128/AAC.00453-16. Print 2016 Dec.

Tedizolid: a new oxazolidinone antimicrobial.

Am J Health Syst Pharm. 2014 Apr 15;71(8):621-33. doi: 10.2146/ajhp130482.

Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone.

Ann Clin Microbiol Antimicrob. 2014 Sep 20;13:46. doi: 10.1186/s12941-014-0046-0.

Efficacy of tedizolid against methicillin-resistant Staphylococcus aureus and Peptostreptococcus anaerobius in thigh mixed-infection mouse model.

J Infect Chemother. 2017 Jun;23(6):368-373. doi: 10.1016/j.jiac.2017.02.013. Epub 2017 Mar 23.

引用本文的文献

Persistence of transferable oxazolidinone resistance genes in enterococcal isolates from a swine farm in China.

Front Microbiol. 2022 Oct 10;13:1010513. doi: 10.3389/fmicb.2022.1010513. eCollection 2022.

The asymmetric Henry reaction as synthetic tool for the preparation of the drugs linezolid and rivaroxaban.

Beilstein J Org Chem. 2022 Apr 14;18:438-445. doi: 10.3762/bjoc.18.46. eCollection 2022.

Prodrugs for Improved Drug Delivery: Lessons Learned from Recently Developed and Marketed Products.

Pharmaceutics. 2020 Oct 29;12(11):1031. doi: 10.3390/pharmaceutics12111031.

Activity of Tedizolid Compared to Linezolid and Five Other Antimicrobial Agents against 332 Anaerobic Isolates, Including Bacteroides fragilis Group, , , and Species.

Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.01088-20.

Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections.

Drug Des Devel Ther. 2016 Dec 22;11:65-82. doi: 10.2147/DDDT.S84667. eCollection 2017.

New agents approved for treatment of acute staphylococcal skin infections.

Arch Med Sci. 2016 Dec 1;12(6):1327-1336. doi: 10.5114/aoms.2016.59838. Epub 2016 May 11.

In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and China.

Eur J Clin Microbiol Infect Dis. 2016 Dec;35(12):1933-1939. doi: 10.1007/s10096-016-2744-3. Epub 2016 Sep 27.

In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.

Antimicrob Agents Chemother. 2015 Oct;59(10):6262-5. doi: 10.1128/AAC.00390-15. Epub 2015 Jul 27.

In vitro activity of tedizolid against gram-positive bacteria in patients with skin and skin structure infections and hospital-acquired pneumonia: a Korean multicenter study.

Ann Lab Med. 2015 Sep;35(5):523-30. doi: 10.3343/alm.2015.35.5.523.

Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.

Drugs. 2015 Feb;75(3):253-70. doi: 10.1007/s40265-015-0352-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验